↓ Skip to main content

Blau Syndrome, the prototypic auto-inflammatory granulomatous disease

Overview of attention for article published in Pediatric Rheumatology, August 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter
3 tweeters
patent
1 patent
googleplus
1 Google+ user

Citations

dimensions_citation
106 Dimensions

Readers on

mendeley
100 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Blau Syndrome, the prototypic auto-inflammatory granulomatous disease
Published in
Pediatric Rheumatology, August 2014
DOI 10.1186/1546-0096-12-33
Pubmed ID
Authors

Carine H Wouters, Anne Maes, Kevin P Foley, John Bertin, Carlos D Rose

Abstract

Blau syndrome is a monogenic disease resulting from mutations in the pattern recognition receptor NOD2, and is phenotypically characterized by the triad of granulomatous polyarthritis, dermatitis and uveitis. This paper reviews briefly the classical clinical features of the disease, as well as more recently described extra-triad symptoms. From an ongoing prospective multicenter study, we provide new data on the natural history of Blau syndrome, focusing on functional status and visual outcome. We also present an update of the range of different NOD2 mutations found in Blau syndrome as well as recent data on morphologic and immunohistochemical characteristics of the Blau granuloma. Finally, emerging insights into pathogenic mechanisms including activation of NOD2 signal transduction, and potential biomarkers of disease activity are discussed.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 100 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
Singapore 1 1%
Unknown 98 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 21 21%
Other 14 14%
Researcher 14 14%
Student > Bachelor 11 11%
Student > Doctoral Student 10 10%
Other 18 18%
Unknown 12 12%
Readers by discipline Count As %
Medicine and Dentistry 53 53%
Biochemistry, Genetics and Molecular Biology 10 10%
Agricultural and Biological Sciences 9 9%
Immunology and Microbiology 5 5%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Other 5 5%
Unknown 15 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 September 2017.
All research outputs
#2,538,258
of 13,940,382 outputs
Outputs from Pediatric Rheumatology
#105
of 406 outputs
Outputs of similar age
#35,852
of 193,365 outputs
Outputs of similar age from Pediatric Rheumatology
#1
of 10 outputs
Altmetric has tracked 13,940,382 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 406 research outputs from this source. They receive a mean Attention Score of 4.6. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,365 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them